Ocular Therapeutix reported a net loss of $13.1 million, or $0.44 per share, in the fourth quarter of 2017 compared with a net loss of $12.8 million, or $0.52 per share, in the fourth quarter of 2016, the company announced in a press release.
The company reported a $63.4 million net loss, or $2.20 per share, for the full year compared with a net loss of $44.7 million, or $1.80 per share, for 2016.
Product sales of ReSure sealant and partner collaborations generated $0.5 million in revenue for the fourth (Read more...)
Uncategorized